NCYT — Novacyt SA Share News

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapNeutral

Market Cap
£29.57m
Enterprise Value
£9.76m
Revenue
£11.58m

REG - Novacyt S.A. - Liquidity Agreement and Total Voting Rights
03/04/2023 13:00Announcement
REG - Novacyt S.A. - Liquidity Agreement and Total Voting Rights
01/03/2023 16:15Announcement
REG - Novacyt S.A. - Liquidity Agreement and Total Voting Rights
01/02/2023 13:30Announcement
REG - Novacyt S.A. - DHSC Claim update – Trial date listed
30/01/2023 07:00Announcement
REG - Novacyt S.A. - Full Year 2022 Trading Update
26/01/2023 07:00Announcement
REG - Novacyt S.A. - Holdings in Company
06/01/2023 12:15Announcement
REG - Novacyt S.A. - Liquidity Agreement and Total Voting Rights
03/01/2023 12:30Announcement
REG - Novacyt S.A. - Non-Executive Director Change
07/12/2022 07:00Announcement
REG - Novacyt S.A. - Approval of genesig COVID-19 3G PCR test in UK
06/12/2022 07:00Announcement
REG - Novacyt S.A. - Liquidity Agreement and Total Voting Rights
01/12/2022 17:00Announcement
REG - Novacyt S.A. - Directorate Change
10/11/2022 07:00Announcement
REG - Novacyt S.A. - Liquidity Agreement and Total Voting Rights
01/11/2022 17:00Announcement
REG - Novacyt S.A. - UK Approval of genesig® SARS-CoV-2 Winterplex® 3G
26/10/2022 07:17Announcement
REG - Novacyt S.A. - Liquidity Agreement and Total Voting Rights
03/10/2022 15:30Announcement
REG - Novacyt S.A. - Half year 2022 results
29/09/2022 07:00Announcement
REG - Novacyt S.A. - Notice of Results and Investor Presentation
15/09/2022 07:00Announcement
REG - Novacyt S.A. - Liquidity Agreement and Total Voting Rights
01/09/2022 12:00Announcement
RCS - Novacyt S.A. - Launch of first fully lyophilised PROmate® assays
04/08/2022 07:15Announcement
REG - Novacyt S.A. - Liquidity Agreement and Total Voting Rights
01/08/2022 14:30Announcement
RCS - Novacyt S.A. - Launch of research-use-only adenovirus F41 assay
28/07/2022 07:16Announcement